Fajiang Mao,maofajiang,Xingli Wu,wuxingli,yuanchenyue,Chenyue Yuan,huanghaiyan,Haiyan Huang,Yanyan Qiu,qiuyanyan,renjianlin,Jianlin Ren,yinpeihao. Allosteric probe-modified liposome loading bufalin-fluorouracil complex for targeted colorectal cancer therapy. Oncol Transl Med, 2022, 8: 239-246.
Allosteric probe-modified liposome loading bufalin-fluorouracil complex for targeted colorectal cancer therapy
Received:June 30, 2022  Revised:October 24, 2022
View Full Text  View/Add Comment  Download reader
KeyWord:bufalin; fluorouracil; colorectal cancer; imaging; therapy
Author NameAffiliationPostcode
Fajiang Mao Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
maofajiang Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese 200071
Xingli Wu Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
wuxingli Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine 
yuanchenyue Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine 
Chenyue Yuan Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
huanghaiyan Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine 
Haiyan Huang Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
Yanyan Qiu Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
qiuyanyan Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine 
renjianlin Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine 
Jianlin Ren Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine 200071
yinpeihao Interventional Cancer Institute of Chinese Integrative Medicine,Putuo Hospital, Shanghai University of Traditional Chinese Medicine 200070
Hits: 1670
Download times: 2076
Abstract:
      Objective Bufalin, the main active anti-tumor monomer of toad venom, is crucial in cancer treatment. However, intrinsic issues, such as poor solubility and systematic toxicity, have considerably mitigated its anticancer functions and caused unwanted side effects. It is essential to develop innovative targeting systems to precisely and efficiently deliver anticancer drugs to achieve satisfying therapeutic efficiency. Methods This work established a novel and more efficient system for simultaneously detecting and killing colorectal cancer cells. The proposed method designed two allosteric probes, a report probe and a recognize probe. The method exhibited high sensitivity towards cell detection via the recognizing probe identifying target cancer cells and the report probe’s signal report. Combining bufalin and fluorouracil endowed better tumor cell inhibition. Results We observed significantly enhanced fluorescence dots surrounding the HCT-116 cell membranes. No fluorescence increments in the other three cells were identified, indicating that the established liposome complex could specifically bind with target cells. In addition, the best ratio of bufalin to fluorouracil was 0.15 and 0.5, respectively. This improved the anti-tumor effects and achieved more than 60% tumor cell inhibition. Conclusion This method will provide new opportunities for intracellular biomolecule detection and targeted cancer cell therapy.
Close